Fair! Already there are stem cell and gene manipulation methods to eliminate abnormal genes like sickle cell and other ‘bad’ genes from our babies, pre-birth or at birth or later. There are many ...

Shoshana Ungerleider is many things: an internal medicine physician, a science journalist, a San Francisco resident, a host ...

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on Two Natural Cap’s Substack. In this article, we will ...

Deion Sanders missed CU football camps required by contract. Fans question his absence, but health issues may explain it.

Identifying new drugs for patients with sickle cell disease is very important, said a senior scientist at the Indian Council ...

Weeks after Deion Sanders revealed he was facing a serious health challenge, the charismatic Colorado Buffaloes coach emerged from his self-imposed exile ...

Isaralgagene civaparvovec is a “potential best-in-class gene therapy for Fabry disease,” according to analysts at H.C.

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela ...

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 ...

Foundation, a nonprofit organization dedicated to providing free life-saving medicines and essential support to individuals ...

This might help: The analyst community's current consensus price target of $77.21 is about 75% above this stock's present price. Finally, add Confluent ( CFLT -0.13%) to your list of the best stocks ...

Vertex Pharmaceuticals locked arms with Ono Pharmaceutical in an exclusive deal to advance povetacicept, targeting B ...